Search Results
Jan 12, 2026, 08:08 ET Alamar Biosciences anuncia el cierre de la financiación de bonos convertibles
Rowe Price Investment Management, Inc. y Braidwell LP participan como nuevos inversores.Stephen Williams, MD, Ph.D., se incorpora como director científico.Rebecca Chambers y Frank Witney, Ph.D., nombrados miembros del
More news about: Alamar Biosciences, Inc.
Jan 12, 2026, 08:00 ET Florida Cancer Specialists & Research Institute Expands Clinical Team in Lake County, Welcomes Aamir Hussain to Statewide Practice
Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes board-certified medical oncologist and hematologist Aamir Hussain, MD to its team of cancer experts at the FCS clinics in Clermont, 1340 N. Hancock Road, Clermont, FL 34711 and in Tavares, 4100 Waterman Way, Tavares, FL
More news about: Florida Cancer Specialists & Research Institute
Jan 12, 2026, 08:00 ET Invictus Therapeutics and Breakthrough T1D Announce Collaboration to Support First-in-Human Trial of Next-Generation Insulin Analog
purpose-built for pump therapy and automated insulin delivery systems. These insulins build on foundational research from the lab of Michael A. Weiss, MD, PhD, MBA, a world leading expert in insulin biophysics. The company's lead investigational candidate is a temperature-stable, ultra-rapid insulin
More news about: Invictus Therapeutics, LLC
Jan 12, 2026, 08:00 ET Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
continues to expect current capital resources to fund operations through cash flow break-evenGERMANTOWN, Md., Jan. 12, 2026 /PRNewswire/ --
More news about: Precigen, Inc.
Jan 12, 2026, 08:00 ET Sebela Pharmaceuticals® Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroesophageal Reflux Disease
package. We expect to bring this important new treatment option to patients and healthcare providers in January next year."Philip O. Katz, MD,† Professor of Medicine at Weill Cornell Medicine, commented, "The emergence of potassium-competitive acid blockers represents an important advance
More news about: Sebela Pharmaceuticals
Jan 12, 2026, 07:32 ET DYNAMIC ALPHA MACRO FUND EARNS #1 MORNINGSTAR CATEGORY RANKING FOR SECOND CONSECUTIVE YEAR
DYMIX's fundamental macro approach leads the Macro Trading category again in 2025ROCKVILLE, Md., Jan. 12, 2026 /PRNewswire/ --
More news about: Advisors Preferred LLC
Jan 12, 2026, 07:21 ET GardaWorld Announces Financial Guidance for the Fiscal Year Ending January 31, 2026
cause actual results to differ materially from those anticipated in the forward-looking statements, see the Risks and Uncertainties section in the MD&A of the Company's financial report for the period ended October 31, 2025.
More news about: GardaWorld Security Corporation
Jan 12, 2026, 07:21 ET GardaWorld Announces Financial Guidance for the Fiscal Year Ending January 31, 2026
cause actual results to differ materially from those anticipated in the forward-looking statements, see the Risks and Uncertainties section in the MD&A of the Company's financial report for the period ended October 31, 2025.
More news about: GardaWorld Security Corporation
Jan 12, 2026, 07:03 ET SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ --
More news about: SciNeuro Pharmaceuticals
Jan 12, 2026, 07:00 ET Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Proliv™Rx pivotal study results represent an important new option for patients who have not responded adequately to medications," said Mark S. George, MD, a Principal Investigator of the MOOD clinical trial and Professor of Psychiatry and Neurology at the Medical University of South Carolina (MUSC).
More news about: Neurolief
Jan 12, 2026, 07:00 ET Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Proliv™Rx pivotal study results represent an important new option for patients who have not responded adequately to medications," said Mark S. George, MD, a Principal Investigator of the MOOD clinical trial and Professor of Psychiatry and Neurology at the Medical University of South Carolina (MUSC).
More news about: Neurolief
Jan 12, 2026, 05:25 ET Nanochon closes $4.1M Seed Prime II Funding Round
criteria."cultivate(MD) Capital Funds is proud to have a significant portion of the oversubscribed Nanochon funding round," said R. Sean Churchill, MD, MBA. "Making a follow on from our initial investment in 2023 was an easy decision as we continue to watch CEO, Ben Holmes, lead Nanochon with his forward
More news about: cultivate(MD)
Jan 12, 2026, 03:31 ET Společnost Alamar Biosciences oznamuje, že poptávka investorů po konvertibilních dluhopisech převýšila nabídku a rozšíření vedoucího týmu
T. Rowe Price Investment Management, Inc. a Braidwell LP se účastní jako noví investoři.Stephen Williams, MD, Ph.D., nastupuje jako vědecký ředitel.Rebecca Chambersová a Frank Witney, Ph.D., byli jmenováni do představenstva.
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 19:02 ET Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt
Rowe Price Investment Management, Inc. und Braidwell LP beteiligen sich als neue InvestorenStephen Williams, MD, Ph.D. tritt als wissenschaftlicher Leiter einRebecca Chambers und Frank Witney, Ph.D., in den Verwaltungsrat berufen
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 18:56 ET Alamar Biosciences annonce la clôture d'un financement par billets convertibles sursouscrits et l'élargissement de l'équipe de direction
T. Rowe Price Investment Management, Inc. et Braidwell LP sont de nouveaux investisseurs.Stephen Williams, MD, Ph.D., devient directeur scientifique.Rebecca Chambers et Frank Witney, Ph.D., nommés au conseil d'administration
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 16:15 ET Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investorsStephen Williams, MD, Ph.D. joins as Chief Scientific OfficerRebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 16:15 ET Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investorsStephen Williams, MD, Ph.D. joins as Chief Scientific OfficerRebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
More news about: Alamar Biosciences, Inc.
Jan 11, 2026, 15:00 ET REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
readinessPresentation at 44th Annual J.P. Morgan Healthcare Conference Wednesday, January 14ROCKVILLE, Md., Jan. 11, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones
More news about: REGENXBIO Inc.
Jan 09, 2026, 13:40 ET AmplifyMD Names Stephen Klasko and Rod Hochman to Board and Advisory Team
two of the nation's most influential healthcare leaders to its governance and advisory ranks. Stephen K. Klasko, MD, MBA, has joined the company's Board of Directors, and Rod Hochman, MD, has joined as a strategic advisor.
More news about: AmplifyMD
Jan 09, 2026, 13:09 ET Rule 10b-5 Securities Class Action Settlements Double During Second Half of 2025
BETHESDA, Md., Jan. 9, 2026 /PRNewswire/ -- Today, Securities Analytics Research (SAR) published the
More news about: SAR
Jan 09, 2026, 13:04 ET Preston Dermatology & Skin Surgery Center Wins Gold and Bronze in Prestigious Annual DIAMOND Awards
/PRNewswire/ -- Board-certified dermatologist Sheel Desai Solomon, MD, FAAD, and her practice, Preston Dermatology & Skin Surgery Center
More news about: Preston Dermatology
Jan 09, 2026, 12:27 ET American Society for Nutrition Calls for Strong Science in National Nutrition Guidance
ASN seeks transparency on the scientific process behind the new DGAsBETHESDA, Md., Jan. 9, 2026 /PRNewswire/ -- The American Society for Nutrition (ASN) supports the broad eating pattern in the newly released Dietary
More news about: American Society for Nutrition (ASN)
Jan 09, 2026, 12:00 ET Marriott Bonvoy Forges Global Partnership with International Cricket Council, Offering Members Unparalleled Access to Global Cricket Events
Marriott Bonvoy appointed Official Accommodation Partner in multi-year strategic partnership.BETHESDA, Md., Jan. 9, 2026 /PRNewswire/ -- Marriott Bonvoy and the International Cricket Council (ICC) have signed a strategic
More news about: Marriott International, Inc.
Jan 09, 2026, 10:00 ET Continued Zenocutuzumab Treatment Beyond Progression Shows Benefit in Patients with NRG1+ Pancreatic Cancer and Cholangiocarcinoma: New Results from the eNRGy Trial Presented at ASCO GI
opportunity for patients with NRG1 fusion-positive pancreatic and biliary cancers, which are often difficult to treat," said Alison M. Schram, MD, Memorial Sloan Kettering and lead author of the presentation. "In this analysis, zenocutuzumab provided ongoing benefit after radiographic progression,
More news about: Partner Therapeutics, Inc.
Jan 09, 2026, 09:02 ET NYC Breast Augmentation Specialist, Plastic Surgeon Dr. Aviva Preminger, Inducted Into Super Doctors Hall of Fame After 10 Consecutive Years of Recognition
Dr. B. Aviva Preminger, founder of Aviva Preminger MD Aesthetic Plastic Surgery, has achieved one of the most prestigious honors in medicine: induction into the Super Doctors Hall of Fame. This elite recognition
More news about: Aviva™ Preminger MD Aesthetic Plastic Surgery